The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Steven R. Goldstein

New York University School of Medicine

New York

NY 10016

USA

[email]@med.nyu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • New York University School of Medicine, New York, NY 10016, USA. 2000 - 2012
  • Department of Obstetrics and Gynecology, New York University Medical Center, New York, New York, USA. 2001 - 2005
  • Department of Obstetrics & Gynecology, Division of Obstetrics and Gynecology Pathology, New York University School of Medicine, New York, USA. 2002

References

  1. Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Goldstein, S.R., Bhattoa, H.P., Neven, P., Cox, D.A., Dowsett, S.A., Alam, J., Sipos, A., Muram, D. Menopause (2012) [Pubmed]
  2. Raloxifene use in clinical practice: efficacy and safety. Goldstein, S.R., Duvernoy, C.S., Calaf, J., Adachi, J.D., Mershon, J.L., Dowsett, S.A., Agnusdei, D., Stuenkel, C.A. Menopause (2009) [Pubmed]
  3. Early pregnancy: normal and abnormal. Goldstein, S.R. Semin. Reprod. Med. (2008) [Pubmed]
  4. Accreditation, certification: why all the confusion?. Goldstein, S.R. Obstet. Gynecol (2007) [Pubmed]
  5. Abnormal uterine bleeding: the role of ultrasound. Goldstein, S.R. Radiol. Clin. North Am. (2006) [Pubmed]
  6. The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound the key?. Goldstein, S.R. Menopause (2005) [Pubmed]
  7. Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Goldstein, S.R., Johnson, S., Watts, N.B., Ciaccia, A.V., Elmerick, D., Muram, D. Menopause (2005) [Pubmed]
  8. Menorrhagia and abnormal bleeding before the menopause. Goldstein, S.R. Best. Pract. Res. Clin. Obstet. Gynaecol (2004) [Pubmed]
  9. Evaluation of endometrial polyps. Goldstein, S.R., Monteagudo, A., Popiolek, D., Mayberry, P., Timor-Tritsch, I. Am. J. Obstet. Gynecol. (2002) [Pubmed]
  10. Controversy about uterine effects and safety of SERMs: the saga continues. Goldstein, S.R. Menopause (2002) [Pubmed]
  11. Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Goldstein, S.R., Nanavati, N. Am. J. Obstet. Gynecol. (2002) [Pubmed]
  12. An update on non-uterine gynaecological effects on raloxifene. Goldstein, S.R. Eur. J. Cancer (2002) [Pubmed]
  13. Raloxifene effect on frequency of surgery for pelvic floor relaxation. Goldstein, S.R., Neven, P., Zhou, L., Taylor, Y.L., Ciaccia, A.V., Plouffe, L. Obstet. Gynecol (2001) [Pubmed]
  14. The effect of SERMs on the endometrium. Goldstein, S.R. Ann. N. Y. Acad. Sci. (2001) [Pubmed]
  15. Update on raloxifene to prevent endometrial-breast cancer. Goldstein, S.R. Eur. J. Cancer (2000) [Pubmed]
 
WikiGenes - Universities